Radical surgery after chemotherapy: A new therapeutic strategy to envision in grade II glioma

Journal of Neuro-Oncology

Volumn 80, Issue 2, 2006, Pages 171-176

  Duffau, Hugues ^a   Taillandier, Luc ^b   Capelle, Laurent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Brain mapping; Chemotherapy; Low grade glioma; Surgery

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN MAPPING; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; FOLLOW UP; FRONTAL LOBE; HUMAN; LANGUAGE DISABILITY; LEFT HEMISPHERE; MALE; NEUROSURGERY; OCCUPATION; OLIGODENDROGLIOMA; PREOPERATIVE CARE; QUALITY OF LIFE; RIGHT HEMISPHERE; SEIZURE; SOCIAL LIFE; SYMPTOMATOLOGY;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CORPUS CALLOSUM; DACARBAZINE; FRONTAL LOBE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; POSTOPERATIVE CARE;

EID: 33750318249     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9168-3     Document Type: Article

References (23)

1. Berger MS, Deliganis AV, Dobbins JD, Keles GE (1994) The effect of extent of resection on recurrence in patients with low-grade cerebral hemisphere gliomas. Cancer 74:1784-1791
2. Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, Van Effenterre R, Capelle L (2005) Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: A comparative study between two series without (1985-1996) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76:845-851
3. Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100:2622-2626
4. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman HA, Twijnstra A (2003) Supratentorial grade II astrocytoma: Biological features and clinical course. Lancet Neurol 2:395-403
5. Kortmann RD (2003) Radiotherapy in low-grade gliomas: Pros. Semin Oncol 30: 29-33
6. van den Bent MJ (2003) Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. Semin Oncol 30:39-44
7. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Criniere E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broet P, Sanson M, Delattre JY (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133-3138
8. Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM (2003) Temozolomide chemotherapy for progressive low-grade glioma: Clinical benefits and radiological response. Ann Oncol 14:1722-1726
9. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, McLendon RE, Gururangan S, Bigner DD, Herndon JE 2nd, Avgeropoulos N, Finlay J, Tourt-Uhlig S, Affronti ML, Evans B, Stafford-Fox V, Zaknoen S, Friedman HS (2003) Phase II of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21:646-651
10. Duffau H (2005) Lessons from brain mapping in surgery for low-grade glioma: Insights into associations between tumors and brain plasticity. Lancet Neurol 4:476-486
11. Duffau H, Gatignol P, Mandonnet E, Peruzzi P, Tzourio-Mazoyer N, Capelle L (2005) New insights into the anatomo-functional connectivity of the semantic system: A study using cortico-subcortical electrostimulations. Brain 128:797-810
12. Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP (2003) Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 169:2126-2128
13. Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, Van Tinteren H, Horenblas S (2003) Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer. J Urol 174:80-85
14. Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, Kim DS (2001) Ten-year survival of patients with locally advanced Stage Ib-IIb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 82:88-93
15. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
16. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C (2002) French Thoracic Cooperative Group: preoperative chemotherapy followed by surgery compared with primary surgery in respectable stage I (Except T1N0), II, and IIa non-small-cell lung cancer. J Clin Oncol 20:247-253
17. Friedman HS, Kokkinakis DM, Pluda J, Friedman AH, Cokgor I, Haglund MM, Ashley DM, Rich J, Dolan ME, Pegg AE, Moschel RC, McLendon RE, Kerby T, Herndon JE, Bigner DD, Schold SC Jr (1998) Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol 16:3570-3575
18. Voloschin AD, Louis DN, Cosgrove GR, Batchelor TT (2005) Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: Case study. Neuro-oncol 7:97-100
19. Kujas M, Lejeune J, Benouaich-Amiel A, Criniere E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka M, Bernier M, Chretien F, Couvelard A, Capelle L, Duffau H, Cornu P, Broet P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K, Delattre JY (2005) Chromosome 1p loss: A favorable prognostic factor in low-grade gliomas. Ann Neurol 58:322-326
20. Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ (2005) Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine and vincristine. Cancer 103:802-809
21. Mandonnet E, Capelle L, Duffau H Extension of paralimbic low-grade gliomas: Towards an anatomical classification based on white matter invasion pattern. J Neurooncol (in press)
22. Duffau H New concepts in surgery of WHO grade II gliomas: Functional brain mapping, connectionism and plasticity. A review. J Neurooncol (in press)
23. Papagikos MA, Shaw EG, Stieber VW (2005) Lessons learned from randomised clinical trials in adult low-grade glioma. Lancet Oncol 6:240-244